Patents by Inventor Joanne M. Meyer

Joanne M. Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
    Publication number: 20030092019
    Abstract: This invention relates to methods and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorder and adolescent conduct disorder. In particular, the invention provides novel variants of CADPKL nucleic acid sequences, as well as novel CADPKL polypeptides encoded by these variant sequences. The variant CADPKL nucleic acid sequences provided by this invention, as well as the variant polypeptides they encode are ones that statistically correlate with the presence of a neuropsychiatric disorder in individuals. The invention therefore also provides methods and compositions for using these variant nucleic acids and polypeptides to diagnose and treat such neuropsychiatric disorders.
    Type: Application
    Filed: April 19, 2002
    Publication date: May 15, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Joanne M. Meyer, Rory Barrington-Martin, Alexander Parker
  • Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia
    Publication number: 20030054345
    Abstract: This invention relates to methods and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorder and adolescent conduct disorder. In particular, the invention provides novel variants of DISC1 and DISC2 nucleic acid sequences, as well as novel DISC1 polypeptides encoded by these variant nucleic acid sequences. The variant DISC1 and DISC2 nucleic acid sequences provided by this invention, and the variant gene products they encode, are ones that correlate with the presence of a neuropsychiatric disorder in individuals. The invention, therefore, also provides methods and compositions for using the variant nucleic acids and polypeptides to diagnose and treat such neuropsychiatric disorders in individuals.
    Type: Application
    Filed: January 24, 2001
    Publication date: March 20, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Joanne M. Meyer, Rory Barrington-Martin, Alexander Parker, Glenn T. Barnes
  • Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
    Publication number: 20030027153
    Abstract: This invention relates to methods and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorder and adolescent conduct disorder. In particular, the invention provides novel variants of CADPKL nucleic acid sequences, as well as novel CADPKL polypeptides encoded by these variant sequences. The variant CADPKL nucleic acid sequences provided by this invention, as well as the variant polypeptides they encode are ones that statistically correlate with the presence of a neuropsychiatric disorder in individuals. The invention therefore also provides methods and compositions for using these variant nucleic acids and polypeptides to diagnose and treat such neuropsychiatric disorders.
    Type: Application
    Filed: August 23, 2001
    Publication date: February 6, 2003
    Inventors: Joanne M. Meyer, Rory Barrington-Martin, Alexander Parker